ASH Oral Presentation
The First-in-Human Dual BCMA and CD19 Targeted FasT CAR-T Cell Therapy for Multiple Myeloma Patients
12:15 PM EST, Saturday,December 5, 2020
Read More
GC007g获得国内首个
供者来源异基因CAR-T临床试验批件
Read More
致力于推动
新型免疫细胞治疗
从实验室走向临床应用
Read More
ast CAR Dual CAR TruUCAR
实时了解更多有关
亘喜的动态新闻
Press Releases
© 2019 Gracell All Rights Reserved 沪ICP备17053245号-1 Design by A+T
Language
中文